Based on ratings from 14 stock analysts, the Patterson Cos Inc stock price is expected to increase by 26.28% in 12 months. This is calculated by using the average 12-month stock price forecast for Patterson Cos Inc. The lowest target is $22 and the highest is $30. Please note analyst price targets are not guaranteed and could be missed completely.
Patterson Cos Inc has a total of 14 Wall St Analyst ratings. There are 4 buy ratings, 9 ratings, and 1 sell ratings. Since most analysts have a buy consensus rating, the expectation is that Patterson Cos Inc will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
These are the latest 20 analyst ratings of PDCO.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Ross Muken Evercore ISI Group | In-Line | $22 | Maintains | Oct 8, 2024 |
Michael Cherny UBS | Neutral | $24 | Maintains | Sep 5, 2024 |
Jeff Johnson Baird | Neutral | $28 | Maintains | Aug 29, 2024 |
Michael Cherny B of A Securities | Buy | $29 | Maintains | Aug 29, 2024 |
Michael Minchak JP Morgan | Neutral | $26 | Maintains | Aug 29, 2024 |
Ross Muken Evercore ISI Group | In-Line | $23 | Maintains | Aug 29, 2024 |
Ross Muken Evercore ISI Group | In-Line | $25 | Maintains | Jul 9, 2024 |
Erin Wright Morgan Stanley | Equal-Weight | $28 | Maintains | Jun 20, 2024 |
Michael Minchak JP Morgan | Neutral | $29 | Maintains | Jun 20, 2024 |
Michael Cherny B of A Securities | Buy | $32 | Maintains | May 20, 2024 |
Evercore ISI Group | In-Line | $27 | Maintains | Apr 26, 2024 |
Michael Minchak JP Morgan | Neutral | $30 | Maintains | Mar 6, 2024 |
Jason Bednar Piper Sandler | Neutral | $28 | Downgrade | Feb 29, 2024 |
Michael Cherny Leerink Partners | Outperform | $36 | Initiates | Feb 26, 2024 |
Nathan Rich Goldman Sachs | Neutral | $30 | Maintains | Dec 1, 2023 |
Erin Wright Morgan Stanley | Equal-Weight | $35 | Maintains | Nov 30, 2023 |
Nathan Rich Goldman Sachs | Neutral | $30 | Maintains | Nov 30, 2023 |
Jason Bednar Piper Sandler | Overweight | $34 | Maintains | Nov 30, 2023 |
Jonathan Block Stifel | Hold | $32 | Reiterates | Nov 28, 2023 |
Jonathan Block Stifel | Hold | $32 | Reiterates | Aug 31, 2023 |
When did it IPO
1992
Staff Count
7,600
Country
United States
Sector/Industry
Healthcare/Medical Distribution
CEO
Mr. Donald J. Zurbay
Market Cap
$1.85B
In 2023, PDCO generated $6.47B in revenue, which was a decrease of -0.43% from the previous year. This can be seen as a signal that PDCO's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - Patterson Companies Inc. appointed Kristin Dietzler as president of Patterson Dental for North America. She has nearly 30 years of experience in healthcare and will join the executive leadership team.
Why It Matters - The appointment of Kristin Dietzler as president could signal strategic shifts and operational improvements at Patterson Dental, potentially impacting profitability and stock performance.
Summary - Investors are optimistic about Patterson Companies due to its diverse product offerings.
Why It Matters - Optimism around Patterson Companies suggests potential growth and stability, which may drive stock prices higher and attract more investment interest.
Summary - Patterson Cos. (PDCO) reported its earnings 30 days ago.
Why It Matters - Earnings reports indicate company performance and can impact stock prices. Patterson Cos.' recent earnings may influence investor sentiment and market positioning.
Summary - Patterson Companies plans to invest in two businesses to enhance its animal health division.
Why It Matters - Patterson Companies' investment in two businesses signals growth potential in its animal health sector, likely enhancing profitability and market competitiveness, impacting stock performance positively.
Summary - Patterson Companies, Inc. (Nasdaq: PDCO) announced acquisitions of Infusion Concepts in the UK and Mountain Vet Supply in the US for its Animal Health business, enhancing its market position.
Why It Matters - Patterson Companies' acquisitions in the animal health sector signal growth potential and market expansion, likely enhancing revenue and competitiveness, which could positively impact stock performance.
Summary - Patterson Companies, Inc. declared a quarterly cash dividend of $0.26 per share, payable on November 1, 2024, to shareholders of record by October 18, 2024.
Why It Matters - The declaration of a quarterly cash dividend signals financial stability and commitment to returning value to shareholders, which can boost investor confidence and attract new investment.